Logo do repositório

Different measures of HMGB1 location in cancer immunology

dc.contributor.authorGorgulho, Carolina Mendonca [UNESP]
dc.contributor.authorMurthy, Pranav
dc.contributor.authorLiotta, Lance
dc.contributor.authorEspina, Virginia
dc.contributor.authorLotze, Michael T.
dc.contributor.authorGalluzzi, L.
dc.contributor.authorRudqvist, N. P.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniv Pittsburgh
dc.contributor.institutionGeorge Mason Univ
dc.date.accessioned2020-12-10T20:01:51Z
dc.date.available2020-12-10T20:01:51Z
dc.date.issued2019-01-01
dc.description.abstractHMGB1 is the most abundant non-histone nuclear protein. It regulates transcriptional access to open areas of chromatin and limits release of DNA with apoptotic death, serving to both inhibit apoptosis and promote DNA repair. When HMGB1 is translocated to the cytosol with many types of cellular stress, it is a powerful inducer of autophagy. It can also be released by activated immune cells and damaged or dying cells into the extracellular space, where it acts as a damage associated molecular pattern (DAMP) molecule, contributing to the pathogenesis and progression of cancer. Here, the most common methodologies to not only measure HMGB1 but also to effectively determine its subcellular localization, which dictates many of HMGB1's different functions, are reviewed.en
dc.description.affiliationSao Paulo State Univ, Botucatu Inst Biosci, Dept Microbiol & Immunol, Tumor Immunol Lab, Botucatu, SP, Brazil
dc.description.affiliationUniv Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA
dc.description.affiliationGeorge Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
dc.description.affiliationUniv Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA
dc.description.affiliationUniv Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA
dc.description.affiliationUnespSao Paulo State Univ, Botucatu Inst Biosci, Dept Microbiol & Immunol, Tumor Immunol Lab, Botucatu, SP, Brazil
dc.format.extent195-217
dc.identifierhttp://dx.doi.org/10.1016/bs.mie.2019.10.011
dc.identifier.citationTumor Immunology And Immunotherapy - Molecular Methods. London: Academic Press Ltd-elsevier Science Ltd, v. 629, p. 195-217, 2019.
dc.identifier.doi10.1016/bs.mie.2019.10.011
dc.identifier.issn0076-6879
dc.identifier.urihttp://hdl.handle.net/11449/196964
dc.identifier.wosWOS:000539028200012
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofTumor Immunology And Immunotherapy - Molecular Methods
dc.sourceWeb of Science
dc.titleDifferent measures of HMGB1 location in cancer immunologyen
dc.typeResenhapt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isOrgUnitOfPublicationab63624f-c491-4ac7-bd2c-767f17ac838d
relation.isOrgUnitOfPublication.latestForDiscoveryab63624f-c491-4ac7-bd2c-767f17ac838d
unesp.author.orcid0000-0001-6569-8647[1]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatupt
unesp.departmentMicrobiologia e Imunologia - IBBpt

Arquivos